DE60032372D1 - Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen - Google Patents

Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen

Info

Publication number
DE60032372D1
DE60032372D1 DE60032372T DE60032372T DE60032372D1 DE 60032372 D1 DE60032372 D1 DE 60032372D1 DE 60032372 T DE60032372 T DE 60032372T DE 60032372 T DE60032372 T DE 60032372T DE 60032372 D1 DE60032372 D1 DE 60032372D1
Authority
DE
Germany
Prior art keywords
nanoparticles
polymeric micelles
preparations containing
containing paclitaxel
medicine preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032372T
Other languages
English (en)
Other versions
DE60032372T2 (de
Inventor
C Burman
Rama Mukherjee
Dhiraj Khattar
Mukesh Kumar
Honey Bala
Rajiv Kumar Shrivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Oncology Ltd
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26324880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60032372(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/401,927 external-priority patent/US6322817B1/en
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Application granted granted Critical
Publication of DE60032372D1 publication Critical patent/DE60032372D1/de
Publication of DE60032372T2 publication Critical patent/DE60032372T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60032372T 1999-09-23 2000-09-21 Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen Expired - Lifetime DE60032372T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/401,927 US6322817B1 (en) 1999-02-17 1999-09-23 Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US401927 1999-09-23
INDE064100 2000-07-11
IN641DE2000 2000-07-11
PCT/US2000/025914 WO2001021174A1 (en) 1999-09-23 2000-09-21 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles

Publications (2)

Publication Number Publication Date
DE60032372D1 true DE60032372D1 (de) 2007-01-25
DE60032372T2 DE60032372T2 (de) 2007-10-11

Family

ID=26324880

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032372T Expired - Lifetime DE60032372T2 (de) 1999-09-23 2000-09-21 Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen

Country Status (6)

Country Link
EP (1) EP1216042B1 (de)
AT (1) ATE347886T1 (de)
AU (1) AU7599900A (de)
CA (1) CA2383241C (de)
DE (1) DE60032372T2 (de)
WO (1) WO2001021174A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10117049A1 (de) * 2001-04-05 2002-10-17 Novartis Ag Zusammensetzung
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
CA2665343C (en) * 2006-10-05 2014-12-16 The Johns Hopkins University Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
CA2710525C (en) * 2007-12-24 2017-08-22 Sun Pharma Advanced Research Company Limited Nanodispersion
MX2011013726A (es) 2009-06-19 2012-02-29 Sun Pharma Advanced Res Co Ltd Nanodispersión de un medicamento y proceso para su preparación.
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
WO2015051349A1 (en) * 2013-10-04 2015-04-09 Sorrento Therapeutics, Inc. Treating metastatic cancer with micellular paclitaxel
CN103603079B (zh) * 2013-11-15 2015-06-03 无锡中科光远生物材料有限公司 一种用于抗癌药物传输的响应型纳米纤维的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
JPH11335267A (ja) * 1998-05-27 1999-12-07 Nano Career Kk 水難溶性薬物を含有するポリマーミセル系

Also Published As

Publication number Publication date
EP1216042A1 (de) 2002-06-26
AU7599900A (en) 2001-04-24
WO2001021174A1 (en) 2001-03-29
CA2383241C (en) 2009-01-20
CA2383241A1 (en) 2001-03-29
ATE347886T1 (de) 2007-01-15
DE60032372T2 (de) 2007-10-11
EP1216042B1 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
ATE429210T1 (de) Orale flüssige zusammensetzungen
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
ATE186212T1 (de) Geschmacksmaskierte pharmazeutische mittel
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
ATE396198T1 (de) 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
BR0207731A (pt) Formulação cosmética compreendendo derivados de flavonóide
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR0211601A (pt) Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
HK1027563A1 (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same.
DE60032372D1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
MXPA04005552A (es) Analogos de vitamina d.
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3781627D1 (de) Indanderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, diese enthaltende pharmazeutische zusammensetzungen und erhaltene zwischenprodukte.
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
WO2005056510A3 (en) Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BURMAN, ANAND, C., GHAZIABAD 201 010 UTTAR PRA, IN

Inventor name: MUKHERJEE, RAMA, GHAZIABAD 201 010 UTTAR PRADE, IN

Inventor name: KHATTAR, DHIRAJ, GHAZIABAD 201 010 UTTAR PRADE, IN

Inventor name: KUMAR, MUKESH, GHAZIABAD 201 010 UTTAR PRADESH, IN

Inventor name: BALA, HONEY, GHAZIABAD 201 010 UTTAR PRADESH, IN

Inventor name: SHRIVASTAVA, RAJIV KUMAR, GHAZIABAD 201 010 UT, IN

8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: FRESENIUS KABI ONCOLOGY LTD., NEW DELHI, IN